Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...

Gain valuable insights into novel therapies, ongoing clinical trials, and future innovations shaping the treatment of ...

Children and adults vaccinated on the recommended hep B series are afforded lifelong protection against the hepatitis B virus (HBV), a highly infectious virus that attacks the liver. Vaccination ...

Kurnool: With a spike in hepatitis B and hepatitis C virus cases, the Clinical Microbiology wing at Nandyal Government ...

The company is dedicated to educating patients, providers, and others on new findings in chronic hepatitis B virus (HBV) infection. Chronic HBV infection is the most common viral infection in ...

In April 2025, Vir Biotechnology Inc. announced a phase 1b/2 platform study framework to evaluate the safety and efficacy of ...

HDV was discovered in patients infected with hepatitis B virus (HBV). It generally makes HBV infections more damaging to the liver. It is a subviral satellite agent that depends upon HBV envelope ...

An in-depth look at Hepatitis D, why it’s so severe, and how new therapies bring hope for better treatment and prevention.

Liver cancer, particularly hepatocellular carcinoma (HCC), has become a major health concern in Uganda. The Uganda Cancer ...

The Food and Drug Administration (FDA) has granted Fast Track designation to PBGENE-HBV, an investigational gene editing therapy for adults with chronic hepatitis B.

Viral hepatitis was the most common cause of infectious disease mortality worldwide after tuberculosis in 2024, according to ...